TELA Bio, Inc. Finite-Lived Intangible Asset, Expected Amortization, after Year Five
TELA Bio, Inc. (TELA) had Finite-Lived Intangible Asset, Expected Amortization, after Year Five of $100.00 thousand as of 2023-12-31, per its 10-K filed 2024-03-22.
Discontinued › Notes › Goodwill and Other › Intangible Asset, Finite-Lived, after Accumulated Amortization, Estimated Amortization Expense, Fiscal Year Maturity
us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive · last filed 2024-03-22
- 2023-12-31: Finite-Lived Intangible Asset, Expected Amortization, after Year Five $100.00K.
- 2022-12-31: Finite-Lived Intangible Asset, Expected Amortization, after Year Five $500.00K.
- 2021-12-31: Finite-Lived Intangible Asset, Expected Amortization, after Year Five $800.00K.
- 2020-12-31: Finite-Lived Intangible Asset, Expected Amortization, after Year Five $1.10M.
| Period end | Finite-Lived Intangible Asset, Expected Amortization, after Year Five |
|---|---|
| 2023-12-31 | $100.00K 10-K · filed 2024-03-22 |
| 2022-12-31 | $500.00K 10-K · filed 2023-03-23 |
| 2021-12-31 | $800.00K 10-K · filed 2022-03-23 |
| 2020-12-31 | $1.10M 10-K · filed 2021-03-25 |
| 2019-12-31 | $1.40M 10-K · filed 2020-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| InspireMD, Inc. (NSPR) | $0.033B |